Omeros (NASDAQ:OMER) executives highlighted two “major successes” in the fourth quarter of 2025 that they said marked a ...
Novartis announced final two-year results from the phase III APPLAUSE-IgAN study of Fabhalta (iptacopan) in IgA nephropathy (IgAN). Fabhalta demonstrated a statistically significant, clinically ...
Access to education means little if girls are denied protection from harassment, cyber-bullying, and online sexual ...
Morning Overview on MSN
Study shows chemo drug azacitidine damages RNA in stressed cells
The chemotherapy drug azacitidine, a frontline treatment for blood cancers such as myelodysplastic syndromes and acute ...
Ikarovec has presented preclinical evidence for IKAR-001, a dual-pathway gene therapy designed to combine complement ...
DecorHint on MSN
This Oceanfront Aquarium In California Delivers A Family Day Trip In April That Actually Feels Worth It
There’s a moment when a place goes from interesting to unforgettable. This is one of those places. Right along the California ...
Exercise physiologists (EPs) are increasingly recognised for their role in supporting people with lived experience of mental ...
Real Simple on MSN
50 last-minute Amazon spring sale deals to shop from Brooks, Michael Kors, and more before they're gone, up to 70% off
Prices start at $5.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results